Advances in the Treatment of Paraproteinemic Neuropathy

被引:0
作者
Eduardo Nobile-Orazio
Mariangela Bianco
Andrea Nozza
机构
[1] Milan University,Neuromuscular and Neuroimmunology Service, Department of Medical Biotechnology and Translational Medicine, Humanitas Clinical and Research Institute
[2] IRCCS,Department of Medical Oncology and Haematology, Humanitas Cancer Center, Humanitas Clinical and Research Institute
来源
Current Treatment Options in Neurology | 2017年 / 19卷
关键词
Immunoglobulin; MAG; MGUS; Monoclonal gammopathy; Multiple myeloma; Neuropathy; POEMS; Rituximab; Therapy; VEGF;
D O I
暂无
中图分类号
学科分类号
摘要
Purpose of review Several advances have been made on the pathogenesis and therapy of neuropathies associated with paraproteinemia (monoclonal gammopathy). It is important for the neurologist to understand the pathogenetic relevance of this association especially when the hematological disease does not require per se any therapy.
引用
收藏
相关论文
共 454 条
[1]  
Kelly JJ(1981)Prevalence of monoclonal protein in peripheral neuropathy Neurology 31 1480-1483
[2]  
Kyle RA(2001)Chronic polyneuropathies in Vest-Agder, Norway Eur J Neurol 8 157-165
[3]  
O’Brien PC(2006)Prevalence of monoclonal gammopathy of undetermined significance N Engl J Med 354 1362-1369
[4]  
Dyck PJ(2010)European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—first revision J Peripher Nerv Syst 15 185-195
[5]  
Mygland Å(1992)Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies Acta Neurol Scand 85 383-390
[6]  
Monstad P(1993)Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies J Neurol Sci 114 193-199
[7]  
Kyle RA(1994)Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy Ann Neurol 1994 416-424
[8]  
Therneau TM(2017)POEMS syndrome: 2017 update on diagnosis, risk stratification, and management Am J Hematol 92 814-829
[9]  
Rajkumar SV(1998)Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome Muscle Nerve 21 1390-1397
[10]  
Larson DR(2002)Patterns of nerve conduction abnormalities in POEMS syndrome Muscle Nerve 26 189-193